AMENDMENT TO SENIOR CONVERTIBLE NOTESSenior Convertible Notes • March 1st, 2024 • Allarity Therapeutics, Inc. • Pharmaceutical preparations
This Amendment to Senior Convertible Notes (this “Amendment”) is made and entered into as of February 27, 2024 (“Effective Date”), by and between Allarity Therapeutics, Inc., a Delaware corporation (the “Company”), and 3i, LP, a Delaware limited partnership (the “Holder”). The Company and the Holder are sometimes hereinafter referred to as the “Parties.”
